Survey of Specimens and Other Materials Stored in Domestic Biobanks in Japan: Survey Report (in Japanese)
Description
This report presents the results of surveys conducted by the research group for the project “A survey study of critical factors affecting utilization of biospecimen in biobanks” funded by the Japan Agency for Medical Research and Development (AMED) (FY2020–2022, PI: MORITA Mizuki).
To advance genomics-based drug discovery research, it is important that researchers make effective use of the various biobanks available, and to that end, it is desirable that the biospecimens stored in Japanese biobanks, together with their associated clinical information, be easy to identify. Although information sources such as AMED's “Biobank Information List” and “Biobank Cross-Search System” are now available, they are not yet sufficient. Our research group therefore conducted a survey of the specimens stored in biobanks in Japan from June to July 2021.
In addition, domestic biobanks are not the only route through which users obtain human biospecimens. Specimens have traditionally also been obtained from hospital clinical departments through collaborative research, or purchased as research reagents through trading companies and similar vendors. Our research group therefore also surveyed trading companies and other vendors that handle human biospecimens.
The results reflect the situation at the time of the surveys (biobanks: June–July 2021; vendors: August–September 2021) and should be interpreted with the notes provided in the report.
Files
Survey Report (Survey of Specimens and Other Materials Stored in Domestic Biobanks in Japan)_202112.pdf
Additional details
Additional titles
- Translated title (Japanese)
- 国内バイオバンクに保管されている検体等の調査 調査報告書
Funding
- Japan Agency for Medical Research and Development
- A survey study of critical factors affecting utilization of biospecimen in biobanks 22kk0305016h0003
Dates
- Created
-
2021-12